Logo image of MRC

MRC GLOBAL INC (MRC) Stock Fundamental Analysis

USA - NYSE:MRC - US55345K1034 - Common Stock

14.62 USD
+0.11 (+0.76%)
Last: 9/26/2025, 8:13:32 PM
14.62 USD
0 (0%)
After Hours: 9/26/2025, 8:13:32 PM
Fundamental Rating

4

MRC gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 49 industry peers in the Trading Companies & Distributors industry. Both the profitability and the financial health of MRC get a neutral evaluation. Nothing too spectacular is happening here. MRC is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

In the past year MRC was profitable.
In the past year MRC had a positive cash flow from operations.
In multiple years MRC reported negative net income over the last 5 years.
MRC had a positive operating cash flow in 4 of the past 5 years.
MRC Yearly Net Income VS EBIT VS OCF VS FCFMRC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M 600M

1.2 Ratios

MRC has a worse Return On Assets (-1.13%) than 71.43% of its industry peers.
With a Return On Equity value of -3.73%, MRC is not doing good in the industry: 69.39% of the companies in the same industry are doing better.
With a Return On Invested Capital value of 5.27%, MRC perfoms like the industry average, outperforming 51.02% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for MRC is in line with the industry average of 10.06%.
The 3 year average ROIC (11.12%) for MRC is well above the current ROIC(5.27%). The reason for the recent decline needs to be investigated.
Industry RankSector Rank
ROA -1.13%
ROE -3.73%
ROIC 5.27%
ROA(3y)3.02%
ROA(5y)-1.99%
ROE(3y)7.53%
ROE(5y)-5.06%
ROIC(3y)11.12%
ROIC(5y)8.3%
MRC Yearly ROA, ROE, ROICMRC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 -20 -30 -40

1.3 Margins

MRC's Profit Margin has improved in the last couple of years.
Looking at the Operating Margin, with a value of 2.91%, MRC is doing worse than 67.35% of the companies in the same industry.
In the last couple of years the Operating Margin of MRC has grown nicely.
MRC has a Gross Margin of 20.01%. This is in the lower half of the industry: MRC underperforms 75.51% of its industry peers.
In the last couple of years the Gross Margin of MRC has grown nicely.
Industry RankSector Rank
OM 2.91%
PM (TTM) N/A
GM 20.01%
OM growth 3Y12.04%
OM growth 5Y9.77%
PM growth 3YN/A
PM growth 5Y16.09%
GM growth 3Y3.58%
GM growth 5Y2.92%
MRC Yearly Profit, Operating, Gross MarginsMRC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20

4

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), MRC is creating some value.
The number of shares outstanding for MRC has been increased compared to 1 year ago.
Compared to 5 years ago, MRC has more shares outstanding
The debt/assets ratio for MRC is higher compared to a year ago.
MRC Yearly Shares OutstandingMRC Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
MRC Yearly Total Debt VS Total AssetsMRC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

2.2 Solvency

An Altman-Z score of 2.19 indicates that MRC is not a great score, but indicates only limited risk for bankruptcy at the moment.
With a Altman-Z score value of 2.19, MRC perfoms like the industry average, outperforming 44.90% of the companies in the same industry.
MRC has a debt to FCF ratio of 4.21. This is a neutral value as MRC would need 4.21 years to pay back of all of its debts.
MRC's Debt to FCF ratio of 4.21 is fine compared to the rest of the industry. MRC outperforms 61.22% of its industry peers.
A Debt/Equity ratio of 0.83 indicates that MRC is somewhat dependend on debt financing.
MRC's Debt to Equity ratio of 0.83 is in line compared to the rest of the industry. MRC outperforms 42.86% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.83
Debt/FCF 4.21
Altman-Z 2.19
ROIC/WACC0.56
WACC9.49%
MRC Yearly LT Debt VS Equity VS FCFMRC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M 800M 1B

2.3 Liquidity

MRC has a Current Ratio of 1.84. This is a normal value and indicates that MRC is financially healthy and should not expect problems in meeting its short term obligations.
MRC has a Current ratio of 1.84. This is comparable to the rest of the industry: MRC outperforms 44.90% of its industry peers.
MRC has a Quick Ratio of 1.00. This is a normal value and indicates that MRC is financially healthy and should not expect problems in meeting its short term obligations.
MRC has a Quick ratio of 1.00. This is in the lower half of the industry: MRC underperforms 61.22% of its industry peers.
Industry RankSector Rank
Current Ratio 1.84
Quick Ratio 1
MRC Yearly Current Assets VS Current LiabilitesMRC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B

4

3. Growth

3.1 Past

The earnings per share for MRC have decreased strongly by -50.00% in the last year.
Measured over the past years, MRC shows a quite strong growth in Earnings Per Share. The EPS has been growing by 13.84% on average per year.
MRC shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -12.48%.
The Revenue has been decreasing by -3.84% on average over the past years.
EPS 1Y (TTM)-50%
EPS 3Y37.51%
EPS 5Y13.84%
EPS Q2Q%-19.35%
Revenue 1Y (TTM)-12.48%
Revenue growth 3Y4.14%
Revenue growth 5Y-3.84%
Sales Q2Q%-4.09%

3.2 Future

MRC is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 24.37% yearly.
Based on estimates for the next years, MRC will show a small growth in Revenue. The Revenue will grow by 3.22% on average per year.
EPS Next Y57.72%
EPS Next 2Y35.98%
EPS Next 3Y25.1%
EPS Next 5Y24.37%
Revenue Next Year-0.25%
Revenue Next 2Y2.55%
Revenue Next 3Y0.64%
Revenue Next 5Y3.22%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
MRC Yearly Revenue VS EstimatesMRC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 1B 2B 3B 4B 5B
MRC Yearly EPS VS EstimatesMRC Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 0.5 -0.5 1 1.5

6

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 27.58, the valuation of MRC can be described as expensive.
MRC's Price/Earnings is on the same level as the industry average.
The average S&P500 Price/Earnings ratio is at 27.32. MRC is around the same levels.
Based on the Price/Forward Earnings ratio of 12.16, the valuation of MRC can be described as correct.
MRC's Price/Forward Earnings ratio is rather cheap when compared to the industry. MRC is cheaper than 85.71% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 22.89. MRC is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE 27.58
Fwd PE 12.16
MRC Price Earnings VS Forward Price EarningsMRC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

The rest of the industry has a similar Enterprise Value to EBITDA ratio as MRC.
MRC's Price/Free Cash Flow ratio is rather cheap when compared to the industry. MRC is cheaper than 85.71% of the companies in the same industry.
Industry RankSector Rank
P/FCF 11.62
EV/EBITDA 12.96
MRC Per share dataMRC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30

4.3 Compensation for Growth

MRC's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as MRC's earnings are expected to grow with 25.10% in the coming years.
PEG (NY)0.48
PEG (5Y)1.99
EPS Next 2Y35.98%
EPS Next 3Y25.1%

0

5. Dividend

5.1 Amount

MRC does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

MRC GLOBAL INC

NYSE:MRC (9/26/2025, 8:13:32 PM)

After market: 14.62 0 (0%)

14.62

+0.11 (+0.76%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryTrading Companies & Distributors
Earnings (Last)08-06 2025-08-06/bmo
Earnings (Next)11-03 2025-11-03/amc
Inst Owners105.46%
Inst Owner Change0.53%
Ins Owners2.15%
Ins Owner Change1.63%
Market Cap1.24B
Analysts82.86
Price Target15.98 (9.3%)
Short Float %2.31%
Short Ratio2.21
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0.27
Dividend Growth(5Y)-1.19%
DP-55%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)11.13%
Min EPS beat(2)1.72%
Max EPS beat(2)20.53%
EPS beat(4)3
Avg EPS beat(4)-51.78%
Min EPS beat(4)-244.01%
Max EPS beat(4)20.53%
EPS beat(8)6
Avg EPS beat(8)-7.52%
EPS beat(12)9
Avg EPS beat(12)-3.89%
EPS beat(16)13
Avg EPS beat(16)46.91%
Revenue beat(2)2
Avg Revenue beat(2)1.11%
Min Revenue beat(2)0.7%
Max Revenue beat(2)1.51%
Revenue beat(4)2
Avg Revenue beat(4)-2%
Min Revenue beat(4)-9.56%
Max Revenue beat(4)1.51%
Revenue beat(8)3
Avg Revenue beat(8)-2.09%
Revenue beat(12)5
Avg Revenue beat(12)-1.71%
Revenue beat(16)7
Avg Revenue beat(16)-1.2%
PT rev (1m)0%
PT rev (3m)1.08%
EPS NQ rev (1m)-8.33%
EPS NQ rev (3m)3.13%
EPS NY rev (1m)-3.79%
EPS NY rev (3m)1.5%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.57%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.82%
Valuation
Industry RankSector Rank
PE 27.58
Fwd PE 12.16
P/S 0.43
P/FCF 11.62
P/OCF 8.58
P/B 2.32
P/tB 9.08
EV/EBITDA 12.96
EPS(TTM)0.53
EY3.63%
EPS(NY)1.2
Fwd EY8.22%
FCF(TTM)1.26
FCFY8.6%
OCF(TTM)1.7
OCFY11.66%
SpS33.89
BVpS6.3
TBVpS1.61
PEG (NY)0.48
PEG (5Y)1.99
Profitability
Industry RankSector Rank
ROA -1.13%
ROE -3.73%
ROCE 7.08%
ROIC 5.27%
ROICexc 5.63%
ROICexgc 8.77%
OM 2.91%
PM (TTM) N/A
GM 20.01%
FCFM 3.71%
ROA(3y)3.02%
ROA(5y)-1.99%
ROE(3y)7.53%
ROE(5y)-5.06%
ROIC(3y)11.12%
ROIC(5y)8.3%
ROICexc(3y)11.97%
ROICexc(5y)8.91%
ROICexgc(3y)19.85%
ROICexgc(5y)14.75%
ROCE(3y)14.93%
ROCE(5y)11.15%
ROICexcg growth 3Y20.91%
ROICexcg growth 5Y16.17%
ROICexc growth 3Y21.43%
ROICexc growth 5Y17.6%
OM growth 3Y12.04%
OM growth 5Y9.77%
PM growth 3YN/A
PM growth 5Y16.09%
GM growth 3Y3.58%
GM growth 5Y2.92%
F-Score3
Asset Turnover1.63
Health
Industry RankSector Rank
Debt/Equity 0.83
Debt/FCF 4.21
Debt/EBITDA 3.56
Cap/Depr 92.68%
Cap/Sales 1.32%
Interest Coverage 3.11
Cash Conversion 116%
Profit Quality N/A
Current Ratio 1.84
Quick Ratio 1
Altman-Z 2.19
F-Score3
WACC9.49%
ROIC/WACC0.56
Cap/Depr(3y)45.24%
Cap/Depr(5y)36.57%
Cap/Sales(3y)0.57%
Cap/Sales(5y)0.5%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-50%
EPS 3Y37.51%
EPS 5Y13.84%
EPS Q2Q%-19.35%
EPS Next Y57.72%
EPS Next 2Y35.98%
EPS Next 3Y25.1%
EPS Next 5Y24.37%
Revenue 1Y (TTM)-12.48%
Revenue growth 3Y4.14%
Revenue growth 5Y-3.84%
Sales Q2Q%-4.09%
Revenue Next Year-0.25%
Revenue Next 2Y2.55%
Revenue Next 3Y0.64%
Revenue Next 5Y3.22%
EBIT growth 1Y-51.45%
EBIT growth 3Y16.67%
EBIT growth 5Y5.56%
EBIT Next Year41.39%
EBIT Next 3Y13.64%
EBIT Next 5Y13.27%
FCF growth 1Y386.36%
FCF growth 3Y75.35%
FCF growth 5Y2.06%
OCF growth 1Y339.39%
OCF growth 3Y70.18%
OCF growth 5Y2.66%